Endometriosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: • Premenopausal women = 18 years old. • Diagnosed with endometriosis (by physical examination, imaging techniques or laparos-copy). • Patients who report one of the endometriosis related pain symptoms dysmenorrhoea, abdominal/pelvic pain or dyspareunia; on average, at least 1 day per week in the last 3 months, with a minimum average pain score on the numeric rating scale of 4. • Ability to understand and speak the Dutch language. • Owning a smartphone. • Ability to understand how to utilize the Experience Sampling Method [ESM] tool.
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: • Change of hormonal medication during the past one month. (for example for endometriosis treatment or fertility treatment). • Surgery planned during the study period. • Already performing yoga or mindfulness during the past 3 months. • Any organic explanation for chronic pelvic pain besides endometriosis. • Pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain reduction on the numeric rating scale [NRS] after 8 weeks. A significant reduction in pain score is defined as a mean difference between groups of at least 1.4 points measured on the NRS. | — |
Secondary
| Measure | Time frame |
|---|---|
| • Quality of life, measured by the Endometriosis Health Profile [EHP-30] (after 8 weeks) • Pain Catastrophizing, measured by the Pain Catastrophizing Scale [PCS] (after 8 weeks) • Affective Symptoms, measured by the Generalized anxiety disorder [GAD-7] and patient health questionnaire [PHQ-9] (after 8 weeks) Outcomes will be assessed by ESM at baseline and after intervention (8 weeks) and results will be compared to the results of the above mentioned validated retrospective questionnaires, measured at 8 weeks. • Pain reduction on the numeric rating scale [NRS] after 4 and 12 weeks. Pain reduction on NRS is assessed by end of week pain score. • Use of analgesics, measured by the BPI questionnaire. • Reduction of dysmenorrhoea on NRS (if applicable) • Reduction of dyspareunia on NRS (if applicable) • The differences in pain reduction on NRS assessed by ESM compared to end of day pain scores [BPI] and end of week pain scores on the NRS. | — |
Contacts
Maxima Medical Center